Experimental and Molecular Medicine (Feb 2024)

Role of UPF1 in lncRNA-HEIH regulation for hepatocellular carcinoma therapy

  • Hyunho Cha,
  • Minwoo Kim,
  • Narae Ahn,
  • Seong Dong Jeong,
  • Elizaveta Ignatova,
  • Sung Wook Chi,
  • Hyeon Ho Kim,
  • Jungwook Hwang

DOI
https://doi.org/10.1038/s12276-024-01158-6
Journal volume & issue
Vol. 56, no. 2
pp. 344 – 354

Abstract

Read online

Abstract UPF1, a novel posttranscriptional regulator, regulates the abundance of transcripts, including long noncoding RNAs (lncRNAs), and thus plays an important role in cell homeostasis. In this study, we revealed that UPF1 regulates the abundance of hepatocellular carcinoma upregulated EZH2-associated lncRNA (lncRNA-HEIH) by binding the CG-rich motif, thereby regulating hepatocellular carcinoma (HCC) tumorigenesis. UPF1-bound lncRNA-HEIH was susceptible to degradation mediated by UPF1 phosphorylation via SMG1 and SMG5. According to analysis of RNA-seq and public data on patients with liver cancer, the expression of lncRNA-HEIH increased the levels of miR-194-5p targets and was inversely correlated with miR-194-5p expression in HCC patients. Furthermore, UPF1 depletion upregulated lncRNA-HEIH, which acts as a decoy of miR-194-5p that targets GNA13, thereby promoting GNA13 expression and HCC proliferation. The UPF1/lncRNA-HEIH/miR-194-5p/GNA13 regulatory axis is suggested to play a crucial role in cell progression and may be a suitable target for HCC therapy.